Medical device company focused on bringing advanced engineering to the field of breast and burn reconstruction. (ASX: AXP)
Please see our current and past investments below:
+ AIRXPANDERS, INC
+ ARCAMED LLC
ARCAMED manufacturers innovative, sophisticated, and durable case-tray systems for the orthopedic and surgical industries.
+ ATLANTIS COMPONENTS, INC.
Dental component manufacturer that utilizes automated design software and integrated machining to produce patient-specific dental abutments. (Acquired by Astra Tech AB)
Developer of synthetic peptides used for bone growth and tissue regeneration in the treatment of musculoskeletal, vascular and chronic wound diseases. (Acquired by Ferring Pharmaceuticals)
+ CELLERATION, INC.
Celleration, Inc. has developed a proprietary therapeutic ultrasound platform. The patented MIST technology causes cellular stimulation while removing bacteria. (Acquired by Alliqua Biomedical)
Medical device company engaged in the development and commercialization of a woven nitinol self expanding stent for treatment of peripheral arterial disease. (Acquired by Abbott Laboratories)
Neochord is a medical device company focused on minimally invasive technology intended to transform the treatment of mitral regurgitation.
+ SCALE COMPUTING
AirXpanders Announces First Commercial U.S. Procedure for AeroForm® Tissue Expander System for Breast Reconstruction
January 18, 2017
US FDA grants de novo clearance to AirXpanders' AeroForm Tissue Expander System for breast reconstruction
December 26, 2016
First Patient Treated in U.S. Randomized Trial of NeoChord’s, Off-Pump, Minimally Invasive Repair for Degenerative Mitral Regurgitation
November 9, 2016